Error: Could not add to watchlist. X

Omthera Pharmaceuticals Inc

+ Watchlist
OMTH:US
Acquired
OMTH:US was acquired by AZN:LN
USD
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (USD)
-
Shares Outstanding (m)
24.414
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Omthera Pharmaceuticals, Inc. provides pharmaceutical products and therapies. The Company develops therapies for abnormalities in blood lipids, dyslipidemia, and cardiovascular diseases. Omthera Pharmaceuticals serves patients worldwide.
ADDRESS
707 State Road
Princeton, NJ 08540
United States
PHONE
1-908-741-4399
  • Gerald L Wisler "Jerry"
    President/CEO/Co-Founder
  • Bernardus N Machielse
    Exec VP/COO
  • Michael H Davidson
    Exec VP/Chief Medical Officer
Show More